
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1078 | 1068 | 1088 | 1238 | 1597 | 2090 |
Fund Return | 7.82% | 6.83% | 8.77% | 7.38% | 9.82% | 7.65% |
Place in category | 122 | 141 | 120 | 103 | 98 | 33 |
% in Category | 25 | 31 | 24 | 25 | 30 | 14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPMorgan Global Income A Div EUR | 17.32B | 1.66 | 1.00 | 1.86 | ||
JPM Global Income Fund A Mth EUR | 17.32B | 1.66 | 0.98 | - | ||
JPMorgan Global Income D div EUR | 17.32B | 1.60 | 0.65 | 1.51 | ||
JPM Global Income A acc EUR | 17.32B | 1.66 | 1.00 | 1.86 | ||
LU0740858492 | 17.32B | 1.61 | 0.64 | 1.50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allianz Europe Equity Growth P2 EUR | 3.05B | 6.92 | 4.48 | 6.85 | ||
Allianz Europe Equity Growth W EUR | 3.05B | 6.93 | 4.52 | 6.89 | ||
LU1645746105 | 3.05B | 6.84 | 4.06 | - | ||
Allianz Europe Equity Growth WT EUR | 3.05B | 6.93 | 4.52 | 6.89 | ||
Allianz Europe Equity Growth A EUR | 3.05B | 6.71 | 3.28 | 5.63 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 5.80 | 248.350 | +0.67% | |
ASML Holding | NL0010273215 | 3.80 | 673.10 | +1.08% | |
Schneider Electric | FR0000121972 | 2.69 | 241.55 | +2.87% | |
JPMorgan Liquidity Funds Euro Liquidity Fund X ( | LU0836346931 | 2.46 | 10,634.710 | +0.01% | |
Novo Nordisk B | DK0062498333 | 2.41 | 546.3 | -0.60% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review